the aid library

LIST OPTIONS

Filter

7324

Unintended Pregnancy and Induced Abortion In Burkina Faso: Causes and Consequences

Bankole A., Hussain R., Sedgh G. et. al. Guttmacher Institute (2014) C2

Induced abortion is permitted in Burkina Faso only to save the life and protect the health of a pregnant woman, or in cases of rape, incest, and severe fetal impairment. As a result, the vast majority of women who end unintended pregnancies do so in secrecy, out of fear of prosecution and to avoi... more

Download (175)

View PDF (195)

WHO Guideline on use of ferritin concentrations to assess iron status in individuals and populations

World Health Organization WHO (2020) C_WHO

This guideline provides global, evidence-informed recommendations on the use of indicators for assessing a population’s iron status and application of the use of ferritin concentrations for monitoring and evaluating iron interventions.

Anywhere But Syria: How 10 Years of Conflict Left Syria’s Displaced Children Without a Sense of Home

Kivelä, L. & Tajima-Simpson, M. Save the Children (2021) CC

After ten years of war, the vast majority of Syria’s children cannot imagine a future in their country, according to a new report by Save the Children. On average, 86% of Syrian refugee children surveyed in Jordan, Lebanon, Turkey and the Netherlands said they would not want to return to their cou... more

Download (108)

View PDF (145)

Don’t Leave Them Alone: The future of the cross-border response in north west Syria

ATAA Humanitarian Relief Association, BINAA for Development, Children Of One world, et al. Save the Children (2021) C1

This report, written by ATAA Humanitarian Relief Association, BINAA for Development, Children Of One world, Hand in Hand for Aid and Development, Horan Foundation, Hurras Network, MARAM Foundation, Orange Organization, Syrian American Medical Society, Save the Children and Shafak Organization, provi... more

Download (206)

View PDF (245)

Technical note: Girls’ Education, Empowerment, and the Elimination of Female Genital Mutilation - arabic version

UN Children's Fund UNICEF (2021) C_UNICEF

The coronavirus disease 2019 (COVID-19) pandemic has created a global and gendered crisis that is compounding existing inequalities and disproportionately affecting girls and women. Emerging evidence from the COVID-19 crisis in 2020 shows school closures, disruptions in essential services and rising... more

Note technique: Éducation, autonomisation des filles et éradication des mutilations génitales féminines

UN Children's Fund UNICEF (2021) C1

Global gendered impacts of the Ukraine crisis on energy access and food security and nutrition

Economic Empowerment Section of UN Women United Nations UN (2022) C1

The war in Ukraine has had devasting impact on women and girls worldwide, widening gender gaps and increasing rates of food insecurity, malnutrition and energy poverty. This brief reviews the available evidence of that impact, recommending urgent attention to its consequences for women and girls. I... more

Download (287)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (141)

View PDF (215)

School underachievement and specific learning difficulties

S. Nag; M. Snowling IACAPAP (2012) C2

Developmental disorders Chapter C.3

Download (151)

View PDF (230)

H2 TIC disorders
recommended

Hannah Metzger, Sina Wanderer & Veit Roessner IACAPAP (2015) C1

Download (579)

View PDF (1186)

Guiding principles for feeding non-breastfed children 6-24 months of age

World Health Organization WHO (2005) C_WHO

Download (2892)

View PDF (2946)

Campus to Clinic Manual. Mentoring Guide for Facilitators

ICAP Nurse Capacity Initiative ICAP; PEPFAR (2013) CC

Building the competence and confidence of nurse and midwife educators ICAP Nurse Capacity Initiative offers its Campus to Clinic Curriculum to empower nursing educators and mentors with a new area of expertise. It opens the door to teach in new ways with confidence. It can be adapted to different c... more